AG-120 (Ivosidenib) is a potent, selective IDH1 inhibitor. It affects metabolic, epigenetic, and HR repair signaling pathways, by binding to IDH1 to reduce 2-HG levels and targeting YTHDC2, effectively inhibiting cancer cell survival and promoting cellular differentiation and apoptosis.
AG-120 (Ivosidenib) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for AG-120 (Ivosidenib) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- AG-120 (Ivosidenib) Mechanism of Action: IDH1 Inhibition in Leukemic Blast Cells Research
- AG-120 (Ivosidenib) Clinical Trials
- AG-120 (Ivosidenib): Selectivity & Specificity
- AG-120 (Ivosidenib) Working Concentration | Cell Culture | Treatment
- AG-120 (Ivosidenib) Solubility in DMSO
- AG-120 (Ivosidenib) Stock Solution
- AG-120 (Ivosidenib) Storage
- AG-120 (Ivosidenib) Stability
- AG-120 (Ivosidenib) Combination Database
- AG-120 (Ivosidenib) Molecular Weight
- AG-120 (Ivosidenib) SMILES
- AG-120 (Ivosidenib) CAS Number
- AG-120 (Ivosidenib) Chemical Structure (2D and 3D)
- AG-120 (Ivosidenib) Sigma (AMBH303C4A12)? Try a better option.
- AG-120 (Ivosidenib) APExBIO (B7805)? Try a better option.
- AG-120 (Ivosidenib) MedChemExpress (HY-18767)? Try a better option.
- AG-120 (Ivosidenib) Cayman (19894)? Try a better option.
- AG-120 (Ivosidenib) SDS｜MSDS